BF Utilities Limited Releases Unaudited Standalone Financial Results for Quarter Ended June 30, 2026
BF Utilities Limited has reported its unaudited standalone financial results and a limited review report for the quarter ending June 30, 2026. The company provided these results as part of its routine operational updates.The announcement specified that while the standalone results have been made available, the consolidation of these figures is pending due to delays in receiving necessary reports from key subsidiaries.
Nandi Infrastructure Corridor Enterprise Ltd. (NICE) and Nandi Economic Corridor Enterprises Ltd. (NECE), which are subsidiaries of BF Utilities Limited, have not yet submitted their unaudited financial results for the quarter ended June 30, 2026.
The company confirmed that it will publish the Unaudited Consolidated Financial Results as soon as these reports are made available by NICE and NECE.
BFUTILITIE Stock Price Movement
As of 1:13 PM, shares of BF Utilities Limited are shedding value by 5.40%, currently trading at ₹530.05 as investors navigate live market activity.The stock has seen notable movement throughout the session, registering a decline of ₹30.25 and trading within an intraday range bounded by a low of ₹526.85 and a high of ₹564.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.